Dual-setting brushite-silica gel cements

Current cement systems in biomedical applications often face limitations in mechanical strength and drug release profiles. While calcium phosphate cements (CPCs) are widely used for their osteoconductive properties, they typically exhibit low compressive strength and rapid drug release. This gap motivated the exploration of composite materials that could enhance mechanical performance and control drug release. Prior research has shown that CPCs alone cannot meet the mechanical demands of load-bearing applications. Additionally, the inability to modulate drug retention has limited their use in sustained delivery systems. No prior work had resolved how to combine CPCs with silica-based materials to achieve both structural and functional improvements. Existing studies have focused on single-phase cements or isolated drug delivery mechanisms. This paper introduces a novel approach by integrating a silica gel phase into a CPC matrix. The study addresses the need for a dual-phase system that can offer both mechanical reinforcement and controlled drug release. It also explores how the interaction between phases affects biological responses.

The study aimed to develop a dual-setting cement that combines a brushite-forming CPC with a silica-based gel to improve mechanical properties and drug retention. The specific problem addressed was the low compressive strength and uncontrolled drug release of conventional CPCs. The motivation stemmed from the need for a material that could support load-bearing applications while providing sustained drug delivery. The researchers sought to understand how the interplay between CPC and silica phases influences mechanical and biological outcomes. They also aimed to determine whether the release of silicate ions or other ions drives the biological response. The study focused on how varying the TEOS content affects phase composition and performance. It also aimed to evaluate the impact of the composite structure on cell proliferation. The goal was to create a cement system that could be tailored for specific biomedical applications.

The researchers prepared a composite cement by combining a CPC powder with a pre-hydrolyzed TEOS solution. The CPC was composed of β-tricalcium phosphate and monocalcium phosphate. The TEOS was hydrolyzed under acidic conditions before mixing. Cement setting occurred through a dissolution-precipitation process. Simultaneously, the condensation of TEOS was initiated by pH changes during setting. The resulting material was an interpenetrating phase composite. The CPC macropores were infiltrated by the silica gel micropores. The mechanical properties were assessed using compressive strength tests. Drug release was monitored using vancomycin as a model drug. The phase composition was analyzed by varying the TEOS content. Cell proliferation was evaluated using hydroxyapatite as a reference.

The composite cement exhibited a compressive strength 5–10 times higher than the CPC reference. The interpenetrating phase structure increased material density. Vancomycin release was significantly reduced compared to the CPC alone. Only 25% of the immobilized drug was released from the composite. The phase composition could be controlled by adjusting the TEOS content. Brushite, monetite, or a biphasic mixture could be formed. Composites with high silicate content showed cell proliferation similar to hydroxyapatite. The biological activity was attributed to phosphate release and magnesium adsorption. Silicate ion release did not appear to influence cell behavior. These findings suggest a new approach to biomedical cement design.

The authors concluded that the dual-setting cement system offers enhanced mechanical properties and controlled drug release. The interpenetrating phase structure contributes to increased compressive strength. The composite material alters drug release kinetics compared to conventional CPCs. The phase composition can be tuned by adjusting the TEOS content. The biological response was linked to phosphate release and magnesium adsorption. Silicate ions did not appear to drive the observed cell proliferation. The findings suggest that this material could be tailored for specific biomedical applications. The study highlights the potential of combining CPCs with silica-based gels for improved performance.